110 related articles for article (PubMed ID: 21717524)
21. PD-L1 expression in malignant salivary gland tumors.
Harada K; Ferdous T; Ueyama Y
BMC Cancer; 2018 Feb; 18(1):156. PubMed ID: 29409471
[TBL] [Abstract][Full Text] [Related]
22. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
23. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer.
Jang JY; Choi N; Ko YH; Chung MK; Son YI; Baek CH; Baek KH; Jeong HS
BMC Cancer; 2018 Jun; 18(1):672. PubMed ID: 29925355
[TBL] [Abstract][Full Text] [Related]
25. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
26. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.
Watabe Y; Mori T; Yoshimoto S; Nomura T; Shibahara T; Yamada T; Honda K
Cancer Med; 2014 Jun; 3(3):613-22. PubMed ID: 24574362
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness evaluation and prognostic factor analysis in patients with minor salivary gland carcinoma of the hard palate].
Liu XK; Zeng ZY; Chen FJ; Guo ZM; Xu GP; Yang AK; Zhang Q
Ai Zheng; 2003 Oct; 22(10):1088-92. PubMed ID: 14558958
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
29. RB1CC1 activates the p16 promoter through the interaction with hSNF5.
Ochi Y; Chano T; Ikebuchi K; Inoue H; Isono T; Arai A; Tameno H; Shimada T; Hisa Y; Okabe H
Oncol Rep; 2011 Oct; 26(4):805-12. PubMed ID: 21637919
[TBL] [Abstract][Full Text] [Related]
30. Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA).
Bjørndal K; Krogdahl A; Therkildsen MH; Overgaard J; Johansen J; Kristensen CA; Homøe P; Sørensen CH; Andersen E; Bundgaard T; Primdahl H; Lambertsen K; Andersen LJ; Godballe C
Oral Oncol; 2012 Feb; 48(2):179-85. PubMed ID: 21968090
[TBL] [Abstract][Full Text] [Related]
31. Management and outcome of patients with malignant salivary gland tumors.
Bell RB; Dierks EJ; Homer L; Potter BE
J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
[TBL] [Abstract][Full Text] [Related]
32. Basal cell adenocarcinoma of the major salivary glands: A population-level study of 509 cases.
Zhan KY; Lentsch EJ
Laryngoscope; 2016 May; 126(5):1086-90. PubMed ID: 26451535
[TBL] [Abstract][Full Text] [Related]
33. Minor salivary gland tumors of the sinonasal region: results of a retrospective analysis with review of literature.
Pantvaidya GH; Vaidya AD; Metgudmath R; Kane SV; D'Cruz AK
Head Neck; 2012 Dec; 34(12):1704-10. PubMed ID: 22290774
[TBL] [Abstract][Full Text] [Related]
34. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome.
Xu B; Aneja A; Ghossein R; Katabi N
Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497
[TBL] [Abstract][Full Text] [Related]
35. Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor.
Wu X; Yu J; Gao G; Wang X; Liu Y; Zhu S; Gong Z
PLoS One; 2015; 10(11):e0143009. PubMed ID: 26569485
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment quantitative
Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
[TBL] [Abstract][Full Text] [Related]
37. Preferential expression of RB1-inducible coiled-coil 1 in terminal differentiated musculoskeletal cells.
Chano T; Saeki Y; Serra M; Matsumoto K; Okabe H
Am J Pathol; 2002 Aug; 161(2):359-64. PubMed ID: 12163359
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas.
Scesnaite A; Jarmalaite S; Mueller M; Agaimy A; Zenk J; Hartmann A; Iro H; Peters B; Schwarz S; Schneider-Stock R
Head Neck; 2014 Sep; 36(9):1258-67. PubMed ID: 25201059
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma.
Liu S; Ruan M; Li S; Wang L; Yang W
J Craniomaxillofac Surg; 2014 Dec; 42(8):1891-6. PubMed ID: 25187376
[TBL] [Abstract][Full Text] [Related]
40. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
